We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.26B
AUM Growth
-$60.9M
Cap. Flow
-$92.3M
Cap. Flow %
-2.83%
Top 10 Hldgs %
25.7%
Holding
357
New
19
Increased
56
Reduced
184
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$40.7M
2
RDDT icon
Reddit
RDDT
+$31.5M
3
MTSI icon
MACOM Technology Solutions
MTSI
+$13.3M
4
FCFS icon
FirstCash
FCFS
+$10.8M
5
DKNG icon
DraftKings
DKNG
+$10.5M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$37.4M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.2M
3
AMZN icon
Amazon
AMZN
+$12.7M
4
CIEN icon
Ciena
CIEN
+$12.1M
5
CNM icon
Core & Main
CNM
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Healthcare 15.69%
3 Financials 15.15%
4 Consumer Discretionary 13.95%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCN
351
Waste Connections
WCN
$42.1B
-5,122
Closed -$900K
WST icon
352
West Pharmaceutical
WST
$24.7B
-2,759
Closed -$724K
XYL icon
353
Xylem
XYL
$28.2B
-7,046
Closed -$1.04M
ZBRA icon
354
Zebra Technologies
ZBRA
$17.8B
-3,162
Closed -$940K
ULS icon
355
UL Solutions
ULS
$15.5B
-20,333
Closed -$1.44M
BWIN
356
Baldwin Insurance Group
BWIN
$2.96B
-228,120
Closed -$6.44M
SI
357
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
-6,535
Closed -$882K

Similar funds

Peregrine Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Peregrine Capital Management held 357 positions worth $3.26B, down 1.8% from $3.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Peregrine Capital Management's Q4 2025 filing shows 19 new, 56 increased, 184 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 42,567 shares worth $45.7M. The largest sale was Exact Sciences, an estimated $37.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2025 buy was Eli Lilly: 42,567 shares worth $45.7M.
  • Peregrine Capital Management added most to DraftKings in Q4 2025, an estimated $10.5M increase.
  • Peregrine Capital Management's biggest Q4 2025 reduction was Exact Sciences, cutting an estimated $37.4M.
  • Peregrine Capital Management fully exited Core & Main in Q4 2025, selling an estimated $11.8M.
  • Peregrine Capital Management's ten largest holdings make up 26% of its $3.26B portfolio in Q4 2025.
  • Peregrine Capital Management opened 19 new positions and closed 64 in Q4 2025.
  • Peregrine Capital Management's portfolio value fell 1.8% quarter-over-quarter to $3.26B.

Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.